MY ACCOUNT


VHL

$324.80
Size
Packaging Requirements for Dry Ice
In stock
Product Details

VHL (von Hippel-Lindau tumor suppressor protein)

  • Species: Human
  • Expression Host: Baculovirus-insect cell
  • Tag: His-tag
  • Purity: 90%
  • Molecular Weight: 26.0 kDa.
  • Gene Accession Number: NM_000551.


Purification and Quality Control
The His-tag recombinant protein is purified by affinity chromatography in combination with FPLC columns.
The purified VHL is greater than 90% homogeneous based on SDS-PAGE analysis.

Unit Definition (Activity)
1 unit equals 1 nanogram of purified protein. 30-100 units (ng) are required for an in vitro transcription assay and protein-protein interaction assay.

Applications
Purified VHL protein has been used for in vitro transcriptional activation and protein-protein interaction assays.

Formulation and Storage
The protein is in 20mM Tris-HCl pH7.9,100mM NaCl, 0.2mM EDTA, 1mM DTT and 20% glycerol. Stored at -70°C before use. Avoid repeated freeze thaw cycles.

Synonym
HRCA1; RCA1; VHL1

Protein Sequence
MPRRAENWDE AEVGAEEAGV EEYGPEEDGG EESGAEESGP EESGPEELGA EEEMEAGRPR
PVLRSVNSRE PSQVIFCNRS PRVVLPVWLN FDGEPQPYPT LPPGTGRRIH SYRGHLWLFR
DAGTHDGLLV NQTELFVPSL NVDGQPIFAN ITLPVYTLKE RCLQVVRSLV KPENYRRLDI
VRSLYEDLED HPNVQKDLER LTQERIAHQR MGD

Background
von Hippel-Lindau (VHL) disease is a hereditary cancer with a predilection for the central nervous system and retina (1). The von Hippel-Lindau tumor suppressor gene is mutated in families with von Hippel-Lindau disease and encodes a protein (VHL) of 213 amino acids with an acidic pentapeptide motif in the N-terminus (2-4). Mutations in the VHL gene result in constitutive expression of many hypoxi-induced genes, at least in part because of increases in the cellular level of hypoxia-inducible transcription factor HIF-1a (5). VHL protein binds to elongin B, elongin C, and Cul2 to form a stable complex that targets hypoxia inducibal factors (HIFs) for degradation and transcriptional regulation (6,7). In addition, VHL protein has also been shown to interact with specific protein kinase C isoforms (8), histone deacetylases and HIF-1 inhibitor (FIH-1) (9).

References:
1. Singh, AD. et al., (2001) Survey of Ophthalmology 46, 117-134
2. Latif, F. et al., (1993) Science 260, 1317-1320
3. Linehan, WM. et al., (1995) J. Am. Med. Assoc. 273, 564-570
4. Duan, DR. et al., (1995) Proc. Natl. Acad. Sci. USA 92, 6459-6463
5. Kamura, T. et al., (2000) Proc. Natl. Acad. Sci. USA 97, 10430-10435
6. Duan, DR. et al., (1995) Science 269, 1402-1406
7. Iwai, K. et al., (1999) Proc. Natl. Acad. Sci. USA 96, 12436-12441
8. Pal, S. et al., (1997) J Biol. Chem. 272, 27509-27512
9. Mahon, PC. et al., (2001) Genes & Dev. 15, 2675-2686




DISCLAIMER

This products is recommended For RESEARCH USE ONLY and is Not qualified for Use in Diagnostic or Therapeutic Procedures.

Save this product for later
Share this product with your friends